AD
(5Z,9alpha,11alpha,13E,15S)-9,11,15-Trihydroxyprosta-5,13-dien-1-oic acid - 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1)(CAS: 38562-01-5)
CAS Number
Related Products
![(3S)-2-{N-[(2S)-1-Ethoxy-1-oxo-4-phenyl-2-butanyl]-L-alanyl}-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic acid hydrochloride (1:1)](https://static.chemtradehub.com/structs/825/82586-55-8-c287.webp)
![1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, potassium salt (1:1)](https://static.chemtradehub.com/structs/124/124750-99-8-91eb.webp)
![(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetyloxy)-1,9-dihydroxy-15-{[(2R,3S)-2-hydroxy-3-phenyl-3-(phenylformamido)propanoyl]oxy}-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0^{3,10}.0^{4,7}]heptadec-13-en-2-yl benzoate](https://static.chemtradehub.com/structs/330/33069-62-4-4aa0.webp)
![N-Pentanoyl-N-{[2'-(1H-tetrazol-5-yl)-4-biphenylyl]methyl}-L-valine](https://static.chemtradehub.com/structs/137/137862-53-4-85fe.webp)
![{(1S,4R)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopenten-1-yl}methanol](https://static.chemtradehub.com/structs/136/136470-78-5-94f8.webp)
![N-(2-Butyl-3-{4-[3-(dibutylamino)propoxy]benzoyl}-1-benzofuran-5-yl)methanesulfonamide hydrochloride (1:1)](https://static.chemtradehub.com/structs/141/141625-93-6-b862.webp)
Other Suppliers for (5Z,9alpha,11alpha,13E,15S)-9,11,15-Trihydroxyprosta-5,13-dien-1-oic acid - 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1)
Specification
Assay 95.0~105.0%
CAS Number: 38562-01-5
Basic Information
Molecular Formula
C24H45NO8
Molecular Weight
475.62 g/mol
EINECS
254-002-3
Physical State
white
Physical Properties
Melting Point
100-101°
Boiling Point
No data available
Flash Point
No data available
Chemical Identifiers
SMILES
CCCCCC(C=CC1C(CC(C1CC=CCCCC(=O)O)O)O)O.C(C(CO)(CO)N)O
InChIKey
IYGXEHDCSOYNKY-RZHHZEQLSA-N
Database References
MDL Number
MFCD00077863
Beilstein Registry Number
4087514
FAQ
The compound (5Z,9alpha,11alpha,13E,15S)-9,11,15-Trihydroxyprosta-5,13-dien-1-oic acid - 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1) (CAS: 38562-01-5) is subject to various regulations including GHS classification, REACH regulations, FDA guidelines for pharmaceutical use, and EPA regulations for environmental handling. It is important to follow the specific guidelines related to its classification and handling.
Yes, there are alternatives to (5Z,9alpha,11alpha,13E,15S)-9,11,15-Trihydroxyprosta-5,13-dien-1-oic acid - 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1) (CAS: 38562-01-5) in synthesis. Common alternatives include other prostaglandin derivatives and prodrugs of prostaglandins. These alternatives can be used depending on the specific requirements of the synthesis process.
The market and research trends for (5Z,9alpha,11alpha,13E,15S)-9,11,15-Trihydroxyprosta-5,13-dien-1-oic acid - 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1) (CAS: 38562-01-5) are focused on its potential therapeutic applications, particularly in the treatment of inflammatory and pain conditions. Research is also exploring its role in drug delivery systems and its interactions with other biological molecules.
Waste containing (5Z,9alpha,11alpha,13E,15S)-9,11,15-Trihydroxyprosta-5,13-dien-1-oic acid - 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1) (CAS: 38562-01-5) should be handled according to local and national regulations. Typically, it should be collected in appropriate containers, labeled, and disposed of through professional waste disposal services. Environmental precautions include ensuring no contamination of water sources during disposal.
Safety Notice
Please verify product specifications and safety data before use. Contact the supplier for detailed safety information.
Always follow proper handling procedures